Bessemer Group Inc. increased its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 331.3% in the fourth quarter, HoldingsChannel.com reports. The firm owned 16,554 shares of the company’s stock after buying an additional 12,716 shares during the quarter. Bessemer Group Inc.’s holdings in Henry Schein were worth $1,156,000 at the end of the most recent quarter.

Several other institutional investors also recently made changes to their positions in the stock. Congress Asset Management Co. MA grew its stake in shares of Henry Schein by 5.0% during the fourth quarter. Congress Asset Management Co. MA now owns 950,314 shares of the company’s stock worth $66,408,000 after purchasing an additional 44,872 shares during the period. BTIM Corp. lifted its holdings in Henry Schein by 6,807.6% during the fourth quarter. BTIM Corp. now owns 196,868 shares of the company’s stock worth $13,757,000 after acquiring an additional 194,018 shares in the last quarter. PGGM Investments lifted its holdings in Henry Schein by 46.1% during the fourth quarter. PGGM Investments now owns 520,800 shares of the company’s stock worth $36,394,000 after acquiring an additional 164,440 shares in the last quarter. Meag Munich Ergo Kapitalanlagegesellschaft MBH bought a new position in Henry Schein during the fourth quarter worth about $2,659,000. Finally, K.J. Harrison & Partners Inc bought a new position in Henry Schein during the fourth quarter worth about $760,000. 90.93% of the stock is owned by institutional investors and hedge funds.

HSIC has been the topic of several recent analyst reports. Morgan Stanley lowered Henry Schein from an “equal weight” rating to an “underweight” rating and set a $88.00 target price on the stock. in a report on Wednesday, December 6th. Evercore ISI initiated coverage on Henry Schein in a report on Thursday, January 4th. They set an “outperform” rating and a $81.00 target price on the stock. Zacks Investment Research lowered Henry Schein from a “hold” rating to a “sell” rating in a report on Monday, November 13th. Robert W. Baird set a $95.00 target price on Henry Schein and gave the stock a “buy” rating in a report on Thursday, October 19th. Finally, Piper Jaffray Companies reiterated a “buy” rating and set a $78.00 target price on shares of Henry Schein in a report on Wednesday, December 27th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $84.23.

In other news, Director Barry J. Alperin sold 5,796 shares of the business’s stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $70.76, for a total value of $410,124.96. Following the sale, the director now directly owns 48,172 shares in the company, valued at $3,408,650.72. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 1.19% of the company’s stock.

Shares of Henry Schein, Inc. (NASDAQ HSIC) opened at $70.85 on Friday. The company has a market capitalization of $11,390.00, a PE ratio of 20.42, a PEG ratio of 1.88 and a beta of 1.00. Henry Schein, Inc. has a twelve month low of $65.28 and a twelve month high of $93.50. The company has a quick ratio of 0.86, a current ratio of 1.55 and a debt-to-equity ratio of 0.30.

COPYRIGHT VIOLATION WARNING: This news story was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this news story on another domain, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The original version of this news story can be read at https://www.thecerbatgem.com/2018/02/09/bessemer-group-inc-has-1-16-million-position-in-henry-schein-inc-hsic.html.

Henry Schein Company Profile

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.